يعرض 1 - 10 نتائج من 18 نتيجة بحث عن '"bacteria screening"', وقت الاستعلام: 1.62s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية

    المصدر: International Journal of Medical Toxicology & Legal Medicine 22(1and2):130-137. 2019

  4. 4
    دورية أكاديمية

    المساهمون: Medicum, HUSLAB, Department of Clinical Chemistry and Hematology, Department of Diagnostics and Therapeutics, Clinicum, HUS Internal Medicine and Rehabilitation

    وصف الملف: application/pdf

    العلاقة: Kouri , T , Holma , T , Kirjavainen , V , Lempiäinen , A , Alagrund , K , Tohmola , N , Pihlajamaa , T , Kouri , V-P , Lehtonen , M , Friman , S & Patari-Sampo , A 2021 , ' UriSed 3 PRO automated microscope in screening bacteriuria at region-wide laboratory organization ' , Clinica Chimica Acta , vol. 516 , pp. 149-156 . https://doi.org/10.1016/j.cca.2021.01.022Test; ORCID: /0000-0001-6714-3688/work/94996456; ORCID: /0000-0002-3282-232X/work/94997993; 0e70c155-6fbf-4c71-a2ce-4a449e13e113; http://hdl.handle.net/10138/330616Test; 000631257500018

  5. 5
    دورية أكاديمية
  6. 6
  7. 7
  8. 8
  9. 9
    تقرير

    المؤلفون: Becton, Dickinson and Company

    المصدر: Zberberg MD, Shorr AF, Mek ST, Vazquez-Gulamet C, Kollef MH. Multdrug restance, approprte l antt therapy and mortaly Gram-negate severe seps and sept shock: a retrospecte cohort study. Cr Care. 2014 Nov 21;18(6):596. do 10.1186/s13054-014-0596-8.
    Bavsky E, Schwaber MJ, CarmelY. How to stem the te of carbapenemase-producg enterobacterceae?: proacte versus reacte strategs. Curr Op fect D. 2010 Aug;23(4):327-31. do 10.1097/QCO.0b013e32833b3571.
    Zberberg MD, Nathanson BH, Sulham K, Fan W, Shorr AF. 30-day readmsn, antts costs and costs of delay to adequate treatment of Enterobacterceae UT pneumon, and seps: a retrospecte cohort study. Antrob Rest fect Control. 2017 Dec 6;6:124. do 10.1186/s13756-017-0286-9. eCollectn 2017.
    Lepelletr D, Berthelot P, Lucet JC, Fournr S, Jarlr V, Grandbastn B; Natnal Workg Group. French recommendatns for the preventn of 'emergg extensely drug-restant bacter' (eXDR) cross-transmsn. J Hosp fect. 2015 Jul;90(3):186-95. do 10.1016/j.jh.2015.04.002. Epub 2015 Apr 24.
    Mak A, Mler MA, Chong G, Monczak Y. Comparon of PCR and culture for screeng of vancomyc-restant Enterococc hhly dparate results for vanA and vanB. J Cl Mrobl. 2009 Dec;47(12):4136-7. do 10.1128/JCM.01547-09. Epub 2009 Oct 21.
    Holzknecht BJ, Hansen DS, Nlsen L, Kaow A, Jarlov JO. Screeng for vancomyc-restant enterococcwh Xpert(R) vanA/vanB: dgnost accuracy and pact on fectn control decn makg. New Mrobes New fect. 2017 Jan 12;16:54-59. do 10.1016/j.nmn2016.12.020. eCollectn 2017 Mar.
    Improving Carbapenemase-Producing Organism (CPO) and Vancomycin-Resistant Enterococcus (VRE) Management With BD Solutions

  10. 10
    رسالة جامعية